MyFinsight
Home
About
Contact
ctmx: the income statement
Download
Download image
Total comprehensive
income (loss)
-$14,158K
(-344.95%↓ Y/Y)
Unrealized (loss) gain on
investments, net of tax
$71K
(61.36%↑ Y/Y)
Net income (loss)
-$14,229K
(-348.06%↓ Y/Y)
Provision for income taxes
$58K
(-4.92%↓ Y/Y)
Income (loss) before
income taxes
-$14,171K
(-344.45%↓ Y/Y)
Other (expense)
income, net
$5K
(171.43%↑ Y/Y)
Interest income
$1,592K
(-5.97%↓ Y/Y)
Income (loss) from
operations
-$15,768K
(-483.56%↓ Y/Y)
Revenues
$5,963K
(-82.16%↓ Y/Y)
Total operating
expenses
$21,731K
(-25.89%↓ Y/Y)
General and
administrative
$6,427K
(-19.19%↓ Y/Y)
Research and development
$15,304K
(-28.38%↓ Y/Y)
Back
Back
Income Statement
source: myfinsight.com
CytomX Therapeutics, Inc. (CTMX)
CytomX Therapeutics, Inc. (CTMX)